Home / Pharmaceutical company intelligence
S.J & G. Fazul Ellahie (pvt) limited. logo
Pharmaceutical company intelligence

S.J & G. Fazul Ellahie (pvt) limited.

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Private pharmaceutical manufacturer · Karachi · Pakistan

Long-established Pakistan pharmaceutical manufacturing and marketing company producing multiple dosage forms for domestic and international markets.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation26 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date20 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
S. J. & G. Fazul Ellahie (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
17, Maqbool Co-op H. Society, Lal M. Choudhry Road, Karachi, Pakistan
Phone
+92 21 111 754 754
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000083 193 linked products · source seen 26 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx194public portfolio records represented
REG161unique registrations represented
IDX193indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+1registry-only registrations
VER0registry-verified exact registrations
PKR193current validated price records
G68generic molecules in indexed catalogue
DF7dosage-form groups
TA12therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage99%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixS.J & G. Fazul Ellahie (pvt) limited.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limitedGenerated 26 Sep 2026Anti-infectives113 · 59%Gastrointestinal & hepatology21 · 11%CNS & mental health16 · 8%Vitamins, minerals & nutrition15 · 8%Cardiovascular7 · 4%Pain & musculoskeletal7 · 4%Respiratory & allergy5 · 3%Other therapeutic areas9 · 5%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioS.J & G. Fazul Ellahie (pvt) limited.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limitedGenerated 26 Sep 2026193presentationsTablet70 · 36%Injection64 · 33%Capsule20 · 10%Suspension17 · 9%Infusion10 · 5%Syrup9 · 5%Other forms3 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionS.J & G. Fazul Ellahie (pvt) limited.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limitedGenerated 26 Sep 2026179comparable productsBelow peer median37 · 21%Near peer median49 · 27%Above peer median93 · 52%Company median price position+5.7%Lowest-price equivalents13Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsS.J & G. Fazul Ellahie (pvt) limited.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limitedGenerated 26 Sep 2026Neutro Pharma (Pvt.) Ltd.,41 shared60% overlapMediate Pharmaceutical Pvt Ltd39 shared57% overlapNabiqasim Industries (Pvt) Ltd.,37 shared54% overlapBosch Pharmaceuticals (Pvt) Ltd.37 shared54% overlapBio-Labs(Pvt) Ltd37 shared54% overlapMacter International Limited35 shared51% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives113 products · 59%
Gastrointestinal & hepatology21 products · 11%
CNS & mental health16 products · 8%
Vitamins, minerals & nutrition15 products · 8%
Cardiovascular7 products · 4%
Pain & musculoskeletal7 products · 4%
Respiratory & allergy5 products · 3%
Fluids & supportive care3 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins20 products · 10%
Vitamins / minerals / hematinics15 products · 8%
Fluoroquinolone antibacterials15 products · 8%
Antivirals12 products · 6%
Antiemetics11 products · 6%
Antimalarials11 products · 6%
Oxazolidinone antibacterials11 products · 6%
Macrolide antibacterials11 products · 6%
Formulation footprint

Dosage forms

Tablet70 products
Injection64 products
Capsule20 products
Suspension17 products
Infusion10 products
Syrup9 products
Solution3 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 VifyOmeprazole 10presentations 10 mg, 20 mg, 40 mg · Capsule, Injection #2 NezkilLinezolid 8presentations 100 mg/5 mL, 400 mg, 600 mg · Suspension, Tablet, Infusion #3 CefastCeftriaxone 7presentations 1 g, 2 g, 250 mg, 500 mg · Injection #4 CinofloxCiprofloxacin 7presentations 100 mg/50 mL, 125 mg/5 mL, 200 mg/100 mL, 250 mg · Infusion, Suspension, Injection #5 ZeclarClarithromycin 6presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet, Injection #6 FenuronIbuprofen 5presentations 200 mg, 400 mg, 400 mg/4 mL, 800 mg/8 mL · Tablet, Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median3721% of comparable products
Near market median49within ±5% of median
Above market median9352% of comparable products
Lowest-price equivalents13ties included
Company median price position +5.7% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Rexamol 500 mgParacetamol · Tablet · 1000's PKR 0.51/tablet-85.9% vs market median Seretron 8 mg/4 mLOndansetron · Injection · 4mlx1's PKR 129.25/mL-48.5% vs market median Maparix 500 mgVancomycin · Injection · 25's PKR 703.46/vial/unit-44.0% vs market median Water for Injection 5 mLWater for Injection · Injection · 100 x 5ml PKR 1.16/mL-42.7% vs market median Maparix 500 mgVancomycin · Injection · Vial PKR 732.77/vial/unit-41.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 41shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 39shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 37shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 37shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 37shared generics Macter International Limited256 products · 93 generics 35shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers160Distinct registrations among indexed, published, presentation-validated products only
Verified price observations378
Products with a verified price193
Products with multiple price observations185
Source records with multiple versions193
Latest portfolio source check22 Sep 2026
Latest effective price date20 Aug 2026
Latest source observation26 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

161 unique registration(s) · 193 indexed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Apritus Aprepitant 40 mg Capsule 2's 074885 PKR 2,056.17 PKR 1,028.09/capsule 15% above median
Apritus Aprepitant 80 mg Capsule 2's 074886 PKR 3,434.01 PKR 1,717.01/capsule 15% above median
Apritus Aprepitant 125 mg Capsule 2's 074887 PKR 5,363.01 PKR 2,681.51/capsule 15% above median
Atrata Atorvastatin 20 mg Tablet 10's 032402 PKR 700.59 PKR 70.06/tablet 50% above median
Atrata Atorvastatin 10 mg Tablet 10's 034873 PKR 360.92 PKR 36.09/tablet 31% above median
Brilanta Cefazolin 500 mg Injection 1's Vial 044317 PKR 128.86 PKR 128.86/vial/unit 7% above median
Brilanta Cefazolin 1 g Injection 1's Vial 044318 PKR 229.76 PKR 229.76/vial/unit 12% above median
Brilanta Cefazolin 250 mg Injection 1's Vial 050705 PKR 85.31 PKR 85.31/vial/unit 14% above median
Care D3 / ml Cholecalciferol 5 mg/mL Injection 25's 083164 PKR 4,751.62 PKR 190.06/vial/unit 13% below median
Care D3 / ml Cholecalciferol 5 mg/mL Injection 1's 083164 PKR 233.18 PKR 233.18/vial/unit 7% above median
Care D3 / ml Cholecalciferol 5 mg/mL Injection 5's 083164 PKR 989.92 PKR 197.98/vial/unit 9% below median
Cefast Ceftriaxone 500 mg IM injection 1's vial 044319 PKR 351.07 PKR 351.07/vial/unit 6% above median
Cefast Ceftriaxone 1 g IM injection 1's vial 044320 PKR 662.90 PKR 662.90/vial/unit 6% above median
Cefast Ceftriaxone 500 mg IV injection 1's vial 044321 PKR 351.07 PKR 351.07/vial/unit 10% above median
Cefast Ceftriaxone 1 g IV injection 1's vial 044322 PKR 662.90 PKR 662.90/vial/unit 9% above median
Cefast Ceftriaxone 250 mg IV injection 1's vial 047278 PKR 208.57 PKR 208.57/vial/unit 9% above median
Cefast Ceftriaxone 250 mg IM injection 1's vial 047279 PKR 208.57 PKR 208.57/vial/unit 6% above median
Cefast Ceftriaxone 2 g IV injection 1's Vial 082281 PKR 946.21 PKR 946.21/vial/unit 13% above median
Cerox Cephalexin 250 mg Capsule 12's 011792 PKR 217.54 PKR 18.13/capsule 18% above median
Cerox Cephalexin 125 mg/5 mL Suspension 60ml 012677 PKR 123.25 PKR 2.05/mL 10% above median
Cerox Cephalexin 500 mg Capsule 12's 012678 PKR 369.25 PKR 30.77/capsule Near median
Cerox Cephalexin 250 mg/5 mL Suspension 60ml 012679 PKR 217.54 PKR 3.63/mL 10% above median
Cezaf Ceftazidime 250 mg Injection 1's vial 048622 PKR 167.83 PKR 167.83/vial/unit Near median
Cezaf Ceftazidime 500 mg Injection 1's vial 048623 PKR 255.30 PKR 255.30/vial/unit Near median
Cezaf Ceftazidime 1 g Injection 1's vial 048624 PKR 479.53 PKR 479.53/vial/unit Near median
Cinoflox Ciprofloxacin 100 mg/50 mL IV infusion Vial 058540 PKR 123.91 PKR 123.91/vial/unit 57% above median
Cinoflox Ciprofloxacin 200 mg/100 mL IV infusion Vial 058541 PKR 247.81 PKR 247.81/vial/unit 20% above median
Cinoflox Ciprofloxacin 125 mg/5 mL Oral suspension 60ml 073850 PKR 191.95 PKR 3.20/mL 15% above median
Cinoflox Ciprofloxacin 250 mg Oral suspension 60ml 073851 PKR 330.42 PKR 5.51/mL No comparator
Cinoflox Ciprofloxacin 400 mg/100 mL IV infusion Vial 076041 PKR 351.90 PKR 351.90/vial/unit 9% above median
Cinoflox Ciprofloxacin 400 mg/200 mL Injection Vial 089238 PKR 335.07 PKR 335.07/vial/unit No comparator
Cinoflox Ciprofloxacin 250 mg/5 mL Suspension 60ml 104378 PKR 330.42 PKR 5.51/mL 7% above median
Cinoflox Cinoflox Ciprofloxacin 125 mg/5 mL Suspension 60ml 104377 PKR 191.95 PKR 3.20/mL 9% below median
Cinoflox-100 Ciprofloxacin 100 mg Tablet 10's 047285 PKR 100.13 PKR 10.01/tablet 6% above median
Cinoflox-250 Ciprofloxacin 250 mg Tablet 10's 019296 PKR 367.95 PKR 36.80/tablet 44% above median
Cinoflox-500 Cinoflox-500 Ciprofloxacin 500 mg Tablet 10's 024599 PKR 392.37 PKR 39.24/tablet 9% below median
Cinoflox-750 Ciprofloxacin 750 mg Tablet 10's 024600 PKR 447.88 PKR 44.79/tablet 13% above median
Clogpid Clopidogrel 75 mg Tablet 10's 032401 PKR 293.11 PKR 29.31/tablet 8% above median
DEXAMETHASONE Dexamethasone 4 mg Injection 25 x 1 ml 011167 PKR 449.35 PKR 17.97/mL Near median
Diazepam Diazepam 10 mg Injection 25 x 2ml 011400 PKR 325.50 PKR 6.51/mL 17% above median
Diazepam Diazepam 10 mg Injection 100 x 2ml 011400 PKR 1,110.86 PKR 5.55/mL 15% below median
Digestine Metoclopramide 40 mg Capsule 3 x 10's 011615 PKR 770.15 PKR 25.67/capsule No comparator
Digestine Metoclopramide 5 mg/5 mL Syrup 50ml 086121 PKR 60.26 PKR 1.21/mL Near median
Digestine Metoclopramide 10 mg/2 mL Injection 10x2 Amp 086487 PKR 407.19 — No comparator
Digestine Metoclopramide 10 mg Tablet 10 x 10's 086488 PKR 239.80 PKR 2.40/tablet 13% above median
Direto Imipenem + Cilastatin 500 mg + 500 mg IV injection 1's 081789 PKR 1,527.00 PKR 1,527.00/vial/unit Near median
Direto Imipenem + Cilastatin 250 mg + 250 mg IV injection 1's 089291 PKR 916.19 PKR 916.19/vial/unit No comparator
Ditopan Ditopan Warfarin 2.5 mg Tablet 100's 061159 PKR 778.38 PKR 7.78/tablet Near median
Dydronix Tablet 10mgRegistry verified Dydrogesterone — — — 137277Official source ↗ No indexed price — —
Edonax Edonax Zoledronic acid 4 mg Injection Vial 055182 PKR 17,297.62 PKR 17,297.62/vial/unit 34% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). S.J & G. Fazul Ellahie (pvt) limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 26, 2026, from https://medinfobase.com/company/s-j-g-fazul-ellahie-pvt-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.